COLUMN GROUP III LP 13D and 13G filings for Revolution Medicines, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 5:22 pm Sale |
2023-12-31 | 13G | Revolution Medicines, Inc. RVMD |
COLUMN GROUP III LP | 46 0.000% |
-3,347,153 (-100.00%) |
Filing |
| 2023-02-13 4:23 pm Unchanged |
2022-12-31 | 13G | Revolution Medicines, Inc. RVMD |
COLUMN GROUP III LP | 3,347,199 3.800% |
0 (Unchanged) |
Filing |
| 2022-02-11 4:23 pm Sale |
2021-12-31 | 13G | Revolution Medicines, Inc. RVMD |
COLUMN GROUP III LP | 3,347,199 4.500% |
-233,007 (-6.51%) |
Filing |
| 2021-02-12 6:25 pm Purchase |
2020-12-31 | 13G | Revolution Medicines, Inc. RVMD |
COLUMN GROUP III LP | 3,580,206 4.900% |
3,580,206 (New Position) |
Filing |